Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bardelli

Showing results (171-180 of 281) with videos related to

Pageof 29
Sort By:
Nature Communications|June 14, 2018
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapiesMariangela Russo, Simona Lamba, Annalisa Lorenzato, et al.
Cancers|December 24, 2021
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational StudyYmera Pignochino, Giovanni Crisafulli, Giorgia Giordano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2016
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patientsAndrea Sartore-Bianchi, Filippo Pietrantonio, Alessio Amatu, et al.
The Journal of Clinical Investigation|July 29, 2010
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimusFederica Di Nicolantonio, Sabrina Arena, Josep Tabernero, et al.
Nature|August 12, 2005
Colorectal cancer: mutations in a signalling pathwayD Williams Parsons, Tian-Li Wang, Yardena Samuels, et al.
Cancers|August 7, 2021
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR PathwaysFederica Invrea, Simona Punzi, Consalvo Petti, et al.
Cancer Research|November 3, 2004
Alterations in vascular gene expression in invasive breast carcinomaBelinda S Parker, Pedram Argani, Brian P Cook, et al.
Cancer Research|October 19, 2016
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor VasculatureMaud-Emmanuelle Gilles, Federica Maione, Mélissande Cossutta, et al.
Cancer Discovery|June 22, 2016
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal CancerFilippo Pietrantonio, Daniele Oddo, Annunziata Gloghini, et al.
Med (New York, N.Y.)|May 19, 2022
Liquid biopsies for residual disease and recurrenceJonathan Chee Ming Wan, Tariq Imdadali Mughal, Pedram Razavi, et al.
Pageof 29

Showing results (171-180 of 281) with videos related to

Sort By:
Pageof 29
Nature Communications|June 14, 2018
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapiesMariangela Russo, Simona Lamba, Annalisa Lorenzato, et al.
Cancers|December 24, 2021
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational StudyYmera Pignochino, Giovanni Crisafulli, Giorgia Giordano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2016
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patientsAndrea Sartore-Bianchi, Filippo Pietrantonio, Alessio Amatu, et al.
The Journal of Clinical Investigation|July 29, 2010
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimusFederica Di Nicolantonio, Sabrina Arena, Josep Tabernero, et al.
Nature|August 12, 2005
Colorectal cancer: mutations in a signalling pathwayD Williams Parsons, Tian-Li Wang, Yardena Samuels, et al.
Cancers|August 7, 2021
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR PathwaysFederica Invrea, Simona Punzi, Consalvo Petti, et al.
Cancer Research|November 3, 2004
Alterations in vascular gene expression in invasive breast carcinomaBelinda S Parker, Pedram Argani, Brian P Cook, et al.
Cancer Research|October 19, 2016
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor VasculatureMaud-Emmanuelle Gilles, Federica Maione, Mélissande Cossutta, et al.
Cancer Discovery|June 22, 2016
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal CancerFilippo Pietrantonio, Daniele Oddo, Annunziata Gloghini, et al.
Med (New York, N.Y.)|May 19, 2022
Liquid biopsies for residual disease and recurrenceJonathan Chee Ming Wan, Tariq Imdadali Mughal, Pedram Razavi, et al.
Pageof 29